Search
HomeWorld Vaccine Congress 2026

Meet us at the World Vaccine Congress 2026

30 March – 2 April 2026 • Washington

The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain. If you are involved in vaccines or new to it because of the pandemic, this is the most important meeting you will be part of. Uniting vaccine experts – sharing ground-breaking knowledge – tackling the pandemic.

Come and meet us

Biointelect is a globally recognised Australian consulting and advisory firm offering a unique blend of full-service Contract Research Organisation (CRO) capabilities and consulting. With deep roots in the full health innovation ecosystem, Biointelect provides end-to-end support across the entire development pathway.

Leah Goodman, Biointelect's Chief Executive Officer
Leah Goodman
Chief Executive Officer
Jacqui Wade
Director, Clinical Affairs & Director Services

CRO services build for velocity and quality.

As a boutique CRO, Biointelect delivers a bespoke, science-driven model that adapts to the specific needs of each study. The experienced team’s agility and cross-functional collaboration ensure high-quality execution, streamlined communication, and fast, informed decision-making. Clients benefit from a single, dedicated point of contact overseeing all aspects of trial delivery, supported by a highly specialised team with deep early-phase expertise and a proven track record across complex clinical trials.

Regulatory without roadblocks.

From early strategy to dossier build and submissions, Biointelect guides ANZ, APAC and global regulatory pathways, coordinating queries, navigating designations to accelerate decision timelines. Our integrated consulting backbone connects R&D, CMC, market access and policy so your regulatory plan is technically sound and commercially rightsized.

Director Services for effortless Australian entry.

Biointelect’s Director Services are particularly valuable for international clients establishing Australian subsidiaries ensuring a smooth entry into the Australian research landscape, backed by Biointelect’s deep local knowledge and regulatory expertise. These services include governance setup, clinical trial oversight, and support for R&D tax claims, ensuring a smooth entry into the Australian research landscape.

Book a Meeting

We are available throughout this event to discuss how we can support your team across the entire development pathway.

Name
Preferred meeting date and time (if known)

World Vaccine Congress

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe since 2000. The World Vaccine Congress Washington will be back on March 30 – April 2, 2026 bringing together the most senior and informed industry experts across the entire vaccine landscape.

We will continue to cover vaccine progress in:  Infectious Diseases, Cancer Immunotherapy, One Health and Veterinary Vaccines, Clinical Development, Manufacture, Safety, Supply, Market Access & Emerging Infectious

From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create ground-breaking progress. this is the most important meeting you will be part of in 2026.

Eri Nishiuchi

Strategic Development and Business Effectiveness

Eri Nishiuchi holds a Bachelor of Business degree from the University of Technology Sydney. Her expertise lies in health systems analysis and client relationship management within the healthcare and life sciences sectors. She also has experience working with patient organisations.

Throughout her career, Eri has provided competitive landscape research support to pharmaceutical and biotech clients across the Asia Pacific region, achieving one of the top client retention rates in the region. Her multilingual abilities have been instrumental in fostering strong relationships with diverse stakeholders.

Eri joined Biointelect in 2024 in a strategic development and business effectiveness role, where her focus will be on conducting market analysis and improving business processes.